InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+5.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Meury William, Director. Insider active across 4 companies, notably Syndax Pharmaceuticals Inc. Aggregated, 10 disclosures have been published. Activity tracked since 2 February 2022. The latest transaction was filed on 2 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations10 total
4,779 shares@ US$116.86Common StockSEC:0001536778-26-000007:0
25,000 shares0Common StockSEC:0000950170-25-016369:0
10,342 shares@ US$330.0055.9% of flowCommon StockSEC:0001140361-24-013928:0
17,000 shares0Common StockSEC:0001562180-24-001217:0
8,694 shares@ US$316.3044.1% of flowCommon StockSEC:0000950170-23-073877:0
35,000 shares@ US$7.11100.0% of flowCommon StockSEC:0001562180-23-006130:0
16,000 shares0Common StockSEC:0001562180-23-000945:0
38,073 shares0Common StockSEC:0000899243-23-000978:0
16,000 shares0Common StockSEC:0001562180-22-001070:0
16,000 shares0Common StockSEC:0001562180-22-001070
10 of 10 declarations
About Meury William
William Meury is a Board Member at Syndax Pharmaceuticals Inc. He contributes to overseeing the company's activities and making strategic decisions. With expertise in the pharmaceutical sector, he plays an important role in guiding the company's research and development initiatives.
